Arkolith/Insider Trading/NRBO/Form 4/A

Kim Na Yeon

Director, 10% OwnerNeuroBo Pharmaceuticals, Inc. (NRBO) · full profile →Form 4/A · filed Jul 28, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 26, 2022Other(J)5K—$05K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-23-084928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML